IL17A and cancer: The findings exhibited that a few crucial cancer-related pathways, including TNF signaling pathway, cell cycle, HIF-1Alpha signaling pathway, IL-17 signaling pathway, and PI3K-Akt signaling pathway were considerably enhanced in the TFs’ downstream targets (Figure 4B).